The price of a drug should be based on its therapeutic benefits – not just what the market will bear

Retrieved on: 2021-01-13 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

The price of a drug should be based on its therapeutic benefits – not just what the market will bear. View article details on hiswai:

Excerpt

Gilead was repurposing Remdesivir for COVID-19, and it was clearly going to be sold to a mass market. After significant public backlash, Gilead ...

Article found on: www.mrt.com